Description:
An impurity of Clopidogrel, an antiplatelet medication used to reduce the risk of heart disease and stroke in those at high risk.
- Molecular Weight: 307.80
- Molecular Formula: C15H14ClNO2S
Purity: ≥95%
Canonical SMILES:
C1CN(CC2=C1SC=C2)C(C3=CC=CC=C3Cl)C(=O)O
InChI:
InChI=1S/C15H14ClNO2S/c16-12-4-2-1-3-11(12)14(15(18)19)17-7-5-13-10(9-17)6-8-20-13/h1-4,6,8,14H,5,7,9H2,(H,18,19)/t14-/m0/s1
InChIKey: DCASRSISIKYPDD-AWEZNQCLSA-N
- Boiling Point: 447.3±45.0°C at 760 mmHg
- Melting Point: 139-141°C
- Solubility: Soluble in Chloroform (Slightly), DMSO (Slightly), Methanol (Slightly)
- Appearance: Solid
- Storage: Store at -20°C
Synonyms:
Clopidogrel carboxylic acid; USP Clopidogrel Related Compound A; Clopidogrel USP Related Compound A; Clopidogrel Related Compound A; (+)-(S)-(o-Chlorophenyl)-6,7-dihydrothieno[3,2-c]pyridine-5(4H)-acetic acid; (2S)-2-(2-chlorophenyl)-2-[6,7-dihydrothieno[3,2-c]-pyridin-5(4H)-yl]acetic acid; Clopidogrel Impurity A; Thieno[3,2-c]pyridine-5(4H)-acetic acid, α-(2-chlorophenyl)-6,7-dihydro-, (αS)-; (αS)-α-(2-Chlorophenyl)-6,7-dihydrothieno[3,2-c]pyridine-5(4H)-acetic acid; (S)-2-(2-Chlorophenyl)-2-(6,7-dihydrothieno[3,2-c]pyridin-5(4H)-yl)acetic acid; SR 26334
More details are to be found on supplier website
